Launching X–Labs for Breakthrough Science Act

HR 6572 establishes the X-Labs Initiative at the National Institutes of Health (NIH), providing long-term funding to eligible research institutions for breakthrough biomedical research. It creates four funding categories: XL01 for foundational science ($5M-$50M/year for 7 years), XL02 for developing research tools ($5M-$50M/year), XL03 for regranting to high-potential projects ($5M-$50M/year), and XL04 for new institution planning ($1M-$5M for 1-3 years). The bill directly affects nonprofits, universities, and for-profit entities with research subsidiaries, requiring them to use funds exclusively for NIH-supported research without competing for other federal research grants during the award period. Key provisions include strict requirements for XL03 regrants to support projects unlikely to secure traditional NIH funding, and annual reporting to Congress on program progress and impact.